FOSTER JONATHAN P. (Exec. Vice President and CFO) purchased 1560.7% of their position (270.27K shares) of MOLECULIN BIOTECH, INC. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+2.71K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−661.00
Price / share
$0.27
Trade value
$176.49
% of position
Common Stock
Shares
+4.33K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−1.05K
Price / share
$0.27
Trade value
$281.42
% of position
Common Stock
Shares
+270.27K
Price / share
$0.37
Trade value
$100K
% of position
Net shares
+275.59K
Net value
$99.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2025 | M · Option Exercise | +2.71K | — | — | 22.6% | 11.99K | 14.70K |
| Common Stock Direct | 6/20/2025 | F · Tax Withholding | −661.00 | $0.27 | $176.49 | 4.5% | 14.70K | 14.04K |
| Common Stock Direct | 6/22/2025 | M · Option Exercise | +4.33K | — | — | 30.8% | 14.04K | 18.37K |
| Common Stock Direct | 6/22/2025 | F · Tax Withholding | −1.05K | $0.27 | $281.42 | 5.7% | 18.37K | 17.32K |
| Common Stock Direct | 6/23/2025 | P · Purchase | +270.27K | $0.37 | $100K | 1560.7% | 17.32K | 287.59K |
| Total | +275.59K | $99.54K | ||||||
Restricted Stock Units
Common Stock
2.71K shares
Shares
−2.71K
Strike price
Held after
231.84K
Exercisable
—
Restricted Stock Units
Common Stock
4.33K shares
Shares
−4.33K
Strike price
Held after
227.51K
Exercisable
—
Series E Warrants
Common Stock
810.81K shares
Shares
−810.81K
Strike price
0.37
Held after
1.04M
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.71K shares | 6/20/2025 | M · Option Exercise | −2.71K | — | 231.84K | |
| Restricted Stock Units Direct | Common Stock4.33K shares | 6/22/2025 | M · Option Exercise | −4.33K | — | 227.51K | |
| Series E Warrants Direct | Common Stock810.81K shares | 6/23/2025 | P · Purchase | −810.81K | 0.37 | — | 1.04M |